# Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/incremental-cost-effectiveness-of-drug-eluting-stents-compared-with-a-third/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Christoph Kaiser,Hans‐Peter Brunner‐La Rocca,Peter Buser,Piero O. Bonetti,Stefan Osswald,A. Linka,Alain Bernheim,Andreas Zutter,Michael J. Zellweger,Leticia Grize,Matthias Pfisterer |
| Citations | 345 |
| DOI | 10.1016/s0140-6736(05)67221-2 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2074019850 |
| PMID | 16154019 |
| Type | article |
| Year | 2005 |

## Paper authors

- [Alain Bernheim](https://scholariq.org/researchers/alain-bernheim/)

## Paper journal

- [The Lancet](https://scholariq.org/journals/the-lancet/)

## Paper primary topic

- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)

## Paper topics

- [Coronary Interventions and Diagnostics](https://scholariq.org/topics/coronary-interventions-and-diagnostics/)
- [Peripheral Artery Disease Management](https://scholariq.org/topics/peripheral-artery-disease-management/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.